Valuation : Biogen Inc.

Market Cap 32.9B 28.38B 26.74B 24.36B 45.53B 3,108B 45.88B 317B 123B 1,589B 124B 121B 5,220B P/E 2026 *
39.6x
P/E 2027 * 19.5x
Enterprise Value 37.84B 32.64B 30.75B 28.02B 52.37B 3,574B 52.76B 364B 141B 1,827B 142B 139B 6,003B EV / Sales 2026 *
3.62x
EV / Sales 2027 * 3.31x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day+3.07%
1 week+0.72%
Current month+2.78%
1 month+9.72%
3 months+17.92%
6 months+18.41%
Current year+26.52%
1 week 213.58
Extreme 213.58
225.59
1 month 199.93
Extreme 199.9301
225.59
Current year 160.36
Extreme 160.3645
225.59
1 year 135.39
Extreme 135.39
225.59
3 years 110.04
Extreme 110.035
270.5
5 years 110.04
Extreme 110.035
332.87
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap. Importance
4/8/26 Sell

Director

-593 0.0004%
9/6/26 Free

Director

1,505 0.0010%
1/5/26 Exercice

Executive/Senior Manager

2,333 0.0016%
Change 5-day change 1-year change 3-year change Capi.($)
+3.07%+0.72%+59.47%-16.66% 32.9B
+3.42%+4.57%+47.44%+2.45% 85.08B
-2.24%+0.77%+523.44%+33.98% 60.21B
+0.95%+0.93%-15.06%-34.62% 59.71B
-1.25%-6.13%-2.08%+33.18% 51.1B
-0.36%-0.95%+8.81%+168.97% 48.73B
+3.06%+0.55%+49.84%+99.15% 26.11B
+0.79%-4.65%-4.11%+197.39% 22.6B
+1.45%-1.24%+64.88%+114.09% 16.42B
-0.83%-4.17%-16.10%+786.97% 15.3B
Average +0.86%-2.20%+71.65%+138.49% 41.82B
Weighted average by Cap. +0.90%-1.54%+93.17%+73.03%

Financials

2026 *2027 *
Net sales 10.45B 9.02B 8.49B 7.74B 14.47B 987B 14.57B 101B 39.03B 505B 39.25B 38.39B 1,658B 10.67B 9.2B 8.67B 7.9B 14.76B 1,008B 14.87B 103B 39.83B 515B 40.05B 39.18B 1,692B
Net income 953M 822M 775M 706M 1.32B 90.03B 1.33B 9.17B 3.56B 46.03B 3.58B 3.5B 151B 1.9B 1.64B 1.54B 1.41B 2.63B 179B 2.65B 18.27B 7.09B 91.73B 7.13B 6.98B 301B
Net Debt 4.94B 4.26B 4.01B 3.66B 6.83B 466B 6.88B 47.5B 18.43B 238B 18.54B 18.13B 783B 2.42B 2.09B 1.97B 1.79B 3.35B 229B 3.37B 23.28B 9.04B 117B 9.09B 8.89B 384B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
02/09/26 US$222.67 +3.07% 1,268,282
01/09/26 US$216.04 -0.28% 785,496
31/08/26 US$216.65 -0.85% 831,004
28/08/26 US$218.50 -1.35% 517,484
27/08/26 US$221.50 +0.19% 497,524
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
222.67USD
Average target price
236.87USD
Spread / Average Target
+6.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock